EBOS Group Limited Share Price and Company Fundamentals
Last traded: Today at 3:59 AM
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and internationally. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition and food products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Key Metrics
PE ratio
33.54
PB ratio
3.44
Dividend yield
3.28%
Beta
0.35
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Medical Distribution / Healthcare |
|---|---|
| Full time employees | 5000 |
| Website | https://www.ebosgroup.com |
| Mailing address | 737 Bourke Street Level 7 Docklands VIC 3008 Australia |
| Phone / Fax | 61 3 9918 5555 / 61 3 9918 5599 |
Dividends
Dividend yield
3.28%
Dividend amount
$1.48
Payout ratio
70.46%
5Y Avg. yield
2.86%
EBOS Group Limited paid $1.48 dividend and the ex-dividend date was 02 Mar 2023.The dividend payout ratio is 70.46%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EBO dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.
EBO's forward dividend amount is $1.06 and the forward dividend yield is 2.32%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Mar 2023, following are the company executives and directors listed on EBOS Group Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. John Cullity | Chief Exec. Officer | 2.15M | |
| Mr. Leonard Hansen | CFO & Chief Accountant | ||
| Ms. Andrea Bell | Chief Information Officer | ||
| Martin Krauskopf | Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations | ||
| Ms. Janelle Cain | Gen. Counsel | ||
| Ms. Jacinta McCarthy | Group Gen. Mang. of HR | ||
| Mr. Simon Bunde | Exec. Gen. Mang. of Strategic Operations, ESG & Innovation | ||
| Ms. Julie Dillon | Chief Exec. Officer of Animal Care | ||
| Mr. Matthew Muscio | Chief Exec. Officer of Medical Technology | ||
| Mr. Brett Barons | Chief Exec. Officer of Symbion |
Profitability and management effectiveness
Profit margin
2.00%
Operating margin
3.45%
Return on assets
4.53%
Return on equity
10.95%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of EBOS Group Limited is and its enterprise value is .
The EBO's stocks Beta value is 0.35 making it 65% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
EBOS Group Limited (NZX:EBO) Frequently Asked Questions
1. What is EBOS Group Limited's Stock Symbol?
EBOS Group Limited trades on NZX under the ticker symbol "EBO".
2. What is EBOS Group Limited's stock price today?
One share of EBO stock can currently be purchased for approximately $45.
3. How can I contact EBOS Group Limited?
EBOS Group Limited's mailing address is 737 Bourke Street Level 7 Docklands VIC 3008 Australia. The company can be reached via phone at 61 3 9918 5555.
4. What is EBOS Group Limited's official website?
The official website of EBOS Group Limited is https://www.ebosgroup.com.